我們已在上線!
進一步了解
ABPWW
Abpro Holdings Warrant
ABPWW
ABPWW
已下市
ABPWW已於2026年2月19日下市。
關於: Abpro Holdings Inc is a biotechnology company dedicated to developing next-generation antibody therapeutics with the goal of improving the lives of patients with severe and life-threatening diseases. It is focused on novel antibody constructs for immuno-oncology and ophthalmology. By leveraging its proprietary DiversImmune and MultiMabTM antibody discovery and engineering platforms. The company is developing a pipeline of next-generation antibodies, both independently and through collaborations with pharmaceutical and research institutions.
員工: 6
新聞
正面
中性
負面
市場情緒
3個月
正面
0%
中性
0%
負面
0%
我們尚未收到任何關於ABPWW的最新新聞文章。
價格圖表採用Lightweight Charts™實作